Tumor ablation is a minimally invasive surgical procedure that uses radiation to destroy cancer cells. A radiofrequency generator is placed over the tumor and increases the power level until the targeted temperature is reached. Once the temperature has been reached, the power level is modulated to maintain the targeted temperature for the duration of the ablation, which usually takes ten to forty-five minutes. Patients are released from the hospital the same day. The procedure is generally performed under a local anesthesia and may be combined with other treatments.
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1270
The radiation used for this procedure is absorbed by the cancer cells in the affected area. It is not harmful to surrounding tissue. A patient is injected with an anesthetic that will reduce the possibility of side effects. After the treatment, the patient can go home the same day. The incision made during the surgery is usually smaller than a needle. Most patients will be able to return to work in a few days.
After the procedure, you may experience some soreness in the area. During the recovery period, you should take pain medication. You may also have nausea and shoulder pain. However, these side effects are very rare. Most patients will be able to go home the same day, whereas some may need to stay overnight. Most patients will be able to return to work or school a day after the procedure. This procedure is typically not painful.
The global tumor ablation devices market was valued at US$ 464.18 million in 2017 and is projected to exhibit a CAGR of 10.2% over the forecast period (2017–2025).
Global Tumor Ablation Devices Market: Drivers
High prevalence of cancer is expected to propel growth of the global tumor ablation devices market over the forecast period. For instance, according to the study, ‘Trends in thyroid cancer incidence in India’, published in May 2018 in the Journal of Clinical Oncology, the incidence rate of thyroid cancer in India in women increased from 2.4 to 3.9 and in men from 0.9 to 1.3, a relative increase of 62% and 48% respectively during 2004/05 to 2013/14.
Moreover, increasing investment in cancer treatment and management is also expected to propel growth of the global tumor ablation devices market over the forecast period. For instance, the government of UK in 2013 had spent around 300 million euros in finding tumors earlier which allow more patients to have access to the latest genetic cancer tests.
North America is expected to witness significant growth in the global tumor ablation devices market, owing to increasing adoption of tumor ablation devices in the region. For instance, For instance, in February, 2017, University of Minnesota used the EDAP TMS product- Ablatherm Robotic HIFU for prostate ablation treatment.
Covid-19 Impact Analysis
Globally, as of 4:14pm CET, 29 December 2021, there have been 281,808,270 confirmed cases of COVID-19, including 5,411,759 deaths, reported to WHO. As of 28 December 2021, a total of 8,687,201,202 vaccine doses have been administered. The pandemic has led to changes in patient care which included reduced personal contacts but increased telephone visits, and delays in diagnostic procedures.
Global Tumor Ablation Devices Market: Competitive Landscape
Major players operating in the global tumor ablation devices market include, Angiodynamics, Abbott Laboratories, Alpinion Medical Systems Co., Ltd., Boston Scientific Corporation, EDAP TMS S.A., Galil Medical Inc., HealthTronics, Inc., Intuitive Surgical, Inc., Johnson & Johnson, Medtronic Plc, NuVasive, Inc., Smith & Nephew Plc., and SonaCare Medical, LLC.
Direct Purchase This Report with Flat USD 2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/1270
Reasons to Buy this Tumor Ablation Devices Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Tumor Ablation Devices Market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Tumor Ablation Devices Market
➡Leading company profiles reveal details of key Tumor Ablation Devices Market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Tumor Ablation Devices Market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Apply Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/1270
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Tumor Ablation Devices Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Tumor Ablation Devices Industry Impact
Chapter 2 Global Tumor Ablation Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Tumor Ablation Devices (Volume and Value) by Type
2.3 Global Tumor Ablation Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Tumor Ablation Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Tumor Ablation Devices Market Analysis
Chapter 6 East Asia Tumor Ablation Devices Market Analysis
Chapter 7 Europe Tumor Ablation Devices Market Analysis
Chapter 8 South Asia Tumor Ablation Devices Market Analysis
Chapter 9 Southeast Asia Tumor Ablation Devices Market Analysis
Chapter 10 Middle East Tumor Ablation Devices Market Analysis
Chapter 11 Africa Tumor Ablation Devices Market Analysis
Chapter 12 Oceania Tumor Ablation Devices Market Analysis
Chapter 13 South America Tumor Ablation Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Tumor Ablation Devices Business
Chapter 15 Global Tumor Ablation Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
View Press Release: https://www.coherentmarketinsights.com/press-release/tumor-ablation-devices-market-to-surge-to-us-101-billion-by-2025-582
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027